DK0969845T3 - Nye terapeutiske kombinationer af mirtazapin og antipsykotika til behandling eller forebyggelse af psykotiske sygdomme - Google Patents

Nye terapeutiske kombinationer af mirtazapin og antipsykotika til behandling eller forebyggelse af psykotiske sygdomme

Info

Publication number
DK0969845T3
DK0969845T3 DK98919209T DK98919209T DK0969845T3 DK 0969845 T3 DK0969845 T3 DK 0969845T3 DK 98919209 T DK98919209 T DK 98919209T DK 98919209 T DK98919209 T DK 98919209T DK 0969845 T3 DK0969845 T3 DK 0969845T3
Authority
DK
Denmark
Prior art keywords
mirtazapine
antipsychotics
prevention
treatment
new therapeutic
Prior art date
Application number
DK98919209T
Other languages
Danish (da)
English (en)
Inventor
Roger Martin Pinder
Christophorus Louis Broekkamp
Hermanus Henricus Ge Berendsen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0969845T3 publication Critical patent/DK0969845T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98919209T 1997-03-27 1998-03-25 Nye terapeutiske kombinationer af mirtazapin og antipsykotika til behandling eller forebyggelse af psykotiske sygdomme DK0969845T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200881 1997-03-27
EP97202785 1997-09-11

Publications (1)

Publication Number Publication Date
DK0969845T3 true DK0969845T3 (da) 2006-06-19

Family

ID=26146283

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98919209T DK0969845T3 (da) 1997-03-27 1998-03-25 Nye terapeutiske kombinationer af mirtazapin og antipsykotika til behandling eller forebyggelse af psykotiske sygdomme

Country Status (25)

Country Link
EP (1) EP0969845B1 (ja)
JP (2) JP4377456B2 (ja)
KR (1) KR100577865B1 (ja)
CN (1) CN1226036C (ja)
AR (1) AR012193A1 (ja)
AT (1) ATE318604T1 (ja)
AU (1) AU726194B2 (ja)
BR (1) BR9808077A (ja)
CA (1) CA2284551C (ja)
CZ (1) CZ298105B6 (ja)
DE (1) DE69833645T2 (ja)
DK (1) DK0969845T3 (ja)
ES (1) ES2259207T3 (ja)
HK (1) HK1023293A1 (ja)
HU (1) HUP0002742A3 (ja)
ID (1) ID22283A (ja)
IL (1) IL123716A (ja)
NO (1) NO994673L (ja)
NZ (1) NZ337618A (ja)
PL (1) PL191449B1 (ja)
PT (1) PT969845E (ja)
RU (1) RU2222330C2 (ja)
TR (1) TR199902334T2 (ja)
TW (1) TW587938B (ja)
WO (1) WO1998043646A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6280763B1 (en) 1999-05-10 2001-08-28 Pierce Management, Llc Apparatus and method for transdermal delivery of bupropion
FR2797399B1 (fr) * 1999-08-13 2002-10-18 Aventis Pharma Sa Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
US6350773B1 (en) 1999-12-10 2002-02-26 American Home Products Corporation Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino{2,3-e}indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
RU2268725C2 (ru) * 2000-01-19 2006-01-27 Акцо Нобель Н.В. Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
EP1795199A3 (en) * 2001-02-06 2007-07-25 AstraZeneca AB Quetiapine for the treatment of substance dependence or substance abuse
ATE360425T1 (de) 2001-02-06 2007-05-15 Astrazeneca Ab Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
JP5547865B2 (ja) 2003-10-29 2014-07-16 ワイス・エルエルシー アプリンドルおよびその誘導体を含む持続放出型医薬組成物
PT1541197E (pt) * 2003-12-02 2009-06-04 Pharmaneuroboost N V Utilização de pipamperona e de um sndri, snri ou ssri para o tratamento de patologias do temperamento ou da ansiedade
US7884096B2 (en) 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1547650A1 (en) * 2003-12-02 2005-06-29 B & B Beheer NV Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7855195B2 (en) 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
WO2005053796A1 (en) * 2003-12-02 2005-06-16 B & B Beheer Nv Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
WO2005117916A1 (en) 2004-06-03 2005-12-15 F. Hoffmann-La Roche Ag Treatment with cisplatin and an egfr-inhibitor
AU2007255724B2 (en) * 2006-06-09 2012-05-10 Dainippon Sumitomo Pharma Co., Ltd. Novel tape preparation
JOP20120083B1 (ar) * 2011-04-05 2021-08-17 Otsuka Pharma Co Ltd توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns
DE102012011839B4 (de) 2012-06-14 2018-03-22 Norbert Müller Verwendung von Interferon-gamma in einem Verfahren zur Behandlung von psychiatrischen Erkrankungen
RU2509560C1 (ru) * 2013-03-22 2014-03-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые терапевтические комбинации миртазапина для применения при болевых расстройствах

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine
EP0431663B1 (en) * 1989-12-06 1994-01-12 Akzo Nobel N.V. Stabilized solutions of psychotropic agents
ZA935078B (en) * 1992-07-15 1994-02-07 Nicolaas Johannes Jaco Loetter Pharmaceutical composition
EP0669128B1 (en) * 1992-11-17 2000-01-05 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same
JPH07242669A (ja) * 1994-03-07 1995-09-19 Akikazu Ogawa 四環系とブチロフェノン誘導体を化学結合した化合物

Also Published As

Publication number Publication date
NZ337618A (en) 2000-06-23
HUP0002742A3 (en) 2003-03-28
PL191449B1 (pl) 2006-05-31
ATE318604T1 (de) 2006-03-15
DE69833645D1 (de) 2006-04-27
EP0969845A1 (en) 2000-01-12
BR9808077A (pt) 2000-03-08
EP0969845B1 (en) 2006-03-01
TR199902334T2 (xx) 2000-01-21
CA2284551C (en) 2007-06-12
PL335890A1 (en) 2000-05-22
NO994673L (no) 1999-11-17
HK1023293A1 (en) 2000-09-08
NO994673D0 (no) 1999-09-24
JP2001521497A (ja) 2001-11-06
TW587938B (en) 2004-05-21
RU2222330C2 (ru) 2004-01-27
ID22283A (id) 1999-09-30
WO1998043646A1 (en) 1998-10-08
AU7213998A (en) 1998-10-22
KR20010005677A (ko) 2001-01-15
CZ298105B6 (cs) 2007-06-27
JP5023315B2 (ja) 2012-09-12
AU726194B2 (en) 2000-11-02
HUP0002742A2 (hu) 2001-05-28
CN1251526A (zh) 2000-04-26
JP4377456B2 (ja) 2009-12-02
DE69833645T2 (de) 2006-08-24
CN1226036C (zh) 2005-11-09
KR100577865B1 (ko) 2006-05-10
CZ343199A3 (cs) 2000-04-12
IL123716A (en) 2001-03-19
ES2259207T3 (es) 2006-09-16
AR012193A1 (es) 2000-09-27
CA2284551A1 (en) 1998-10-08
JP2009280596A (ja) 2009-12-03
IL123716A0 (en) 1998-12-06
PT969845E (pt) 2006-05-31

Similar Documents

Publication Publication Date Title
DK0969845T3 (da) Nye terapeutiske kombinationer af mirtazapin og antipsykotika til behandling eller forebyggelse af psykotiske sygdomme
DE60026996D1 (de) Plasmabehandlungsapparat, dessen elektrodenstruktur und struktur der bühne
NO994014L (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
DK1041990T3 (da) Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin
DK1023050T3 (da) Nye formuleringer af farmakologiske midler, fremgangsmåder til fremstillingen deraf og fremgangsmåder til anvendelsen deraf
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
DK0944631T3 (da) Nye substituerede pyrazolderivater til behandling af hjertekredslöbssygdomme
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
DK1339406T3 (da) Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
DK1224205T3 (da) 5-Beta-sapogenin- og pseudosapogeninderivater og deres anvendelse ved behandling af demens
NO990433D0 (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
DK1231920T3 (da) Anvendelse af epinastin til behandling af allergisk rhinitis/conjunctivitis
DK1165510T3 (da) 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
NO20005885D0 (no) Kombinasjonsterapi for behandling av refraktær depresjon
IS6137A (is) Meðhöndlun á hugsýkistruflunum
NO20023448D0 (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
NO983512D0 (no) Midler for behandling og forhindring av AIDS
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
ATE292107T1 (de) Verwendung von carbonylaminoderivaten gegen zentralnervensystem-störungen
NO994258L (no) Anvendelse av levobupivakain for behandling av ansiktsmigrene
DK1121356T3 (da) 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser
NO984624L (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav